methylprednisolone acetate is one of 165 small molecule programs targeting Low back pain. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
778 competitors in Osteoarthritis
methylprednisolone acetate
Toradol
Platelet Rich Plasma
Voltaren
Bayer Aspirin
Enbrel
MS Contin
Glucophage
Protonix
Ozone
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details